COVID-19 patient management

The COVID-19 pandemic is an ongoing, unprecedented global health challenge.

bioMérieux is proud to be a part of the global response with the development of three of the first commercially available diagnostic tests for SARS-CoV-2, along with additional critical tests for COVID-19 patients management.

Every COVID-19 patient comes with a unique profile and experiences the disease differently. Patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.

Add to your selection

Do you need more information?

Contact us

A partner you can count on for COVID-19 management

Show in media library: 

 

COVID-19 patient management: A transversal approach

Patients with suspected COVID-19 present with a broad array of symptoms – many of which can also be caused by other diseases. Additionally, patients with serious COVID-19 infections frequently experience secondary opportunistic infections.

COVID-19 patient management requires the healthcare team to be alert to the patient’s varied needs from primary diagnosis to the recovery period.

Throughout the patient pathway, diagnostic tests provide vital information to support improved patient care decision-making.

 

PRIMARY DIAGNOSIS

Download brochure

COVID-19 R-GENE® SARS-COV-2 RESPI R-GENE® and

EMAG®

Real-time PCR test that can be run on most commercial PCR platforms

CE-IVD

Download brochure

BIOFIRE® Respiratory 2.1 Panel (RP2.1)*

BIOFIRE® Respiratory 2.1plus Panel (RP2.1plus)**

Includes SARS-CoV-2 plus 21 (22 for RP2.1plus) other common respiratory pathogens, for use on BIOFIRE® FILMARRAY® platforms

* US FDA De Novo Authorization

** CE-IVD

Download brochure

VIDAS® SARS-COV-2 IgM

VIDAS® SARS-COV-2 IgG

and VIDAS® SARS-COV2-IgGII

Serological tests that run on VIDAS® platforms.

Three assays to better follow antibody responses.

Assays for the  detection of immunoglobulin IgG and IgM specific for the SARS‑CoV‑2 receptor-binding domain (RBD) of the spike protein in human serum or plasma and assessment of the level of IgG anti-SARS-CoV-2 antibodies

CE-IVD

SEVERITY ASSESSMENT

VIDAS® B·R·A·H·M·S PCT™

VIDAS® D-Dimer Exclusion™ II

VIDAS® High Sensitive Troponin I

VIDAS® NT-proBNP2

VIDAS® Ferritin

Inflammation, coagulation and cardiac biomarkers
NEPHROCHECK®

Acute Kidney Injury biomarker

IDENTIFY POTENTIAL CO-INFECTIONS AND SECONDARY INFECTIONS
VIDAS® B·R·A·H·M·S PCT™

Specific biomarker of severe bacterial infection and sepsis
BACT/ALERT®

Family of automated microbial detection systems and blood culture media

BIOFIRE® RP2.1 / RP2.1plus Panel

Multiplex PCR for detection of respiratory tract infections (virus, bacteria)
BIOFIRE® PN/PNplus Panel

Multiplex PCR for detection of lower respiratory tract infections (virus, bacteria, antimicrobial resistance genes)
PREVI® COLOR GRAM

Automated Gram staining
VITEK® MS PRIME

Mass spectrometry for identification of pathogens

Respiratory R-GENE®tests and

EMAG® & NUCLISENS® extraction reagents

A range of real-time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases
CHROMID® chromogenic media

Chromogenic media for growth and identification of pathogens

ANTIMICROBIAL TREATMENT SELECTION AND MONITORING

For potential co-infections and secondary infections
VIDAS® B·R·A·H·M·S PCT™

Specific biomarker of severe bacterial infection and sepsis
VITEK® 2

Microbial identification and Antimicrobial susceptibility testing
ETEST®

MIC for challenging situations

OUTCOME ASSESSMENT / DISCHARGE / FOLLOW-UP
COVID-19 R-GENE® SARS-COV-2 RESPI R-GENE® , EMAG® and NUCLISENS® extraction reagents
VIDAS® SARS-COV-2 IgM, SARS-COV-2 IgG, and SARS-COV2-IgGII

Availability of products range is subject to local regulatory approvals, allocation priorities, supply chain policies etc. Please check with your local bioMérieux representative to know more.

 

 

DOWNLOAD THE GUIDE : DIAGNOSTIC TOOLS FOR THE MANAGEMENT OF COVID-19 PATIENTS

 

 

 

COVID-19 WEBINAR SERIES

Fascinating insights from experts around the world

bioMérieux is committed to support high quality medical education for the ultimate benefits of patients.

Head to our Medical Affairs page for our series of webinars featuring experts from around the world on SARS-CoV-2 and COVID-19.

From various specialities, they share insights, lines of investigation, emerging questions and potential solutions.

Multiplex PCR for detection of upper and lower respiratory tract infections (virus, bacteria, antimicrobial resistance genes).

Click to see products of this solution
The solution contains the products below. Click on the products to see the details
Pioneering diagnostics